Skip to content
SPC Logo

Lansoprazole 15 mg orodispersible tablets

Last Updated on eMC 10-Apr-2017 View document  | Ranbaxy (UK) Limited a Sun Pharmaceutical Company Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 10-Apr-2017 and displayed until Current

Reasons for adding or updating:

  • Change to section 4.3 - Contraindications
  • Change to section 4.6 - Fertility, pregnancy and lactation
  • Change to section 4.8 - Undesirable effects
  • Change to section 6.5 - Nature and contents of container
  • Change to section 10 - Date of revision of the text

Date of revision of text on the SPC: 14-Feb-2017

Legal Category:POM

Black Triangle (CHM): NO

Free-text change information supplied by the pharmaceutical company:

PRAC & QRD

Updated on 30-Nov-2016 and displayed until 10-Apr-2017

Reasons for adding or updating:

  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC

Legal Category:POM

Black Triangle (CHM): NO

Company contact details

Ranbaxy (UK) Limited a Sun Pharmaceutical Company

Company image
Address

5th Floor, Hyde Park, Hayes, 3, 11 Millington Road, Hayes, UB3 4AZ, UK

E-mail
Medical Information e-mail
Telephone

+44 (0) 208 848 8688

Medical Information Direct Line

+44 (0) 208 848 8688

Out of Hours contact

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

lansoprazole

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue